|
|
Volumn 24, Issue 4, 2007, Pages 784-795
|
|
Lamivudine and interferon versus lamivudine monotherapy for HBeAg-positive hepatitis B treatment: A meta-analysis of randomized, controlled trials
|
|
Author keywords
Combination therapy; Hepatitis B; Interferon; Lamivudine; Meta analysis
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PEGINTERFERON ALPHA;
PEGINTERFERON ALPHA2A;
VIRUS DNA;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
MACROGOL DERIVATIVE;
ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
DISEASE ACTIVITY;
FOLLOW UP;
HEPATITIS B;
HISTOLOGY;
HUMAN;
META ANALYSIS;
MONOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SEROCONVERSION;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TREATMENT RESPONSE;
ADOLESCENT;
ADULT;
AGED;
BLOOD;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG COMBINATION;
FEMALE;
MALE;
MIDDLE AGED;
VIROLOGY;
ADOLESCENT;
ADULT;
AGED;
ANTI-HIV AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B;
HEPATITIS B E ANTIGENS;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
MALE;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 38449097207
PISSN: 0741238X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02849971 Document Type: Article |
|
Times cited : (6)
|
|
References (31)
|
